Other
Western University Biochemistry 3385A Midterm Study Guide
- Institution
- University Of Western Ontario (UWO )
This is a full study guide for UWO's Biochemistry 3385A Midterm Exam.
[Show more]
Seller
Follow
Content preview
BIOCHEM3385 MIDTERM REVIEWTopic 1 Lecture 1: Cancer Key Concepts Pt. 1
Cancer: excessive cell proliferation, tumor forms
Usually benign but harmful if block organ function/hormone imbalance
Malignant tumors invade other areas
Causes of Cancer: lifestyle, genetics, and environment
Types of Cancer:
Epithelial Cells – carcinoma, squamous cell carcinoma, adenocarcinoma
Non-Epithelial Cells (connective tissue, neural cells, hematopoietic tissue) –
sarcoma, glioma/glioblastoma/neuroblastoma, leukemia/lymphoma
Tumorigenesis – tumor formation
Cells acquire many mutations (can be somatic/germline, genomic instability)
Tumors are monoclonal (comes from one cell)
Allows them to proliferate and escape apoptosis
Genes Involved in Cancer:
Oncogenes – normally regulate cell growth/survival (proto-oncogenes), loss of
cell control when hyperactive
Activation through overexpression, gene amplification, mutation that
keeps product active
Ex. Ras, Bcl-2
Tumor Suppressors – prevent over proliferation and induce apoptosis, loss of
cell control when deactivated
Deactivation through gene mutations (1 allele or 2 alleles), promoter
mutations, epigenetic events (ex. methylation)
Ex. p53 (transcription factor, also responds to cell cycle arrest, DNA
repair, apoptosis)
Ex. pRB (transcription factor, also regulates cell cycle)
6 “Hallmarks of Cancer” -malignant
Self-sufficient w/o growth signals
Doesn’t respond to anti-growth signals
Limitless replication
Evade apoptosis
Sustained angiogenesis
Tissue invasion/metastasis
Topic 1 Lecture 2: Cancer Key Concepts Pt. 2
Cell growth/proliferation regulated by signalling cascades, starting from extracellular
signals that bind to transmembrane receptors (ex. growth factors), leading to transcription
in nucleus
The RAS PATHWAY (start of signalling) - oncogene
o Growth factor/signal binds to membrane receptor (upstream stimulatory signal)
o Conformational change, next unit binds
Either Grb2, or Shc+Grb2
o This contains a GEF called Sos, removes GDP from Ras and allows GTP to bind
= active Ras (can induce the next pathway)
, The MAPK/ERK PATHWAY (activated by Ras) – kinase phosphorylation cascade
o Ras binds to Raf (kinase)
o Raf activates MEK (phos)
o MEK activates ERK (phos)
o ERK has many targets including nucleus (activates/alters transcription factors)
IN CANCER: mutation in Ras or Raf to make them hyperactive
The AKT/PKB PATHWAY (activated by Ras)
o Ras binds to PI3K (kinase), activated
o PI3K phos PIP3 (inositol lipid in membrane), activated
o PIP3 is docking site for AKT/PKB, activated (cell growth, anti-apoptotic)
PTEN is inhibitor (tumor suppressor), dephos PIP3 so AKT/PKB can’t
bind to it
IN CANCER: PI3K hyperactivation (either d/t mutation in Ras or PI3K),
PTEN deactivation (mutation – more common)
The Wnt-B-catenin Pathway (not activated by Ras) – stimulates gene transcription for
cell proliferation
o Complex containing APC, GSK-3B and B-catenin
Phosphorylates B-catenin, targets it for degradation
But with Wnt signal from membrane receptor, activates Dishevelled
inhibitor of APC complex
Complex cannot target B-catenin for degradation
B-catenin enters nucleus, activates transcription of genes
o FAP (familial adenomatous polyposis) – genetic cancer, many polyps
Mutation in APC gene, pathway always active w/o needing Wnt signal
Can also have mutations in p53 and Ras
The Invasion-Metastasis Cascade:
o Larger tumor = increased risk of metastasis
o Starts with primary tumor formation
Localized Invasion (out of basal membrane into stroma)
Intravasation (into blood/lymph)
Transport
Arrest in Various Organs (cells may become trapped; if not proceed to
general circulation)
Extravasation (out from vessels into tissue)
Colonization (in foreign tissue)
Familial Breast Cancer (genetic) – case of Shanna Larsen
o Mutations in BRCA1 and BRCA2 (involved in DNA repair)
Sporadic Breast Cancer
o Types based on histology, stage of cell transformation, tumor size/metastasis,
receptor status (what’s involved – HER2, estrogen/progesterone receptors or triple
negative)
o Prevention: genetic testing, vaccines (HepB, HPV)
o Diagnostic/Treatment: identify tumor markers and involved pathways
Topic 1 Lecture 3: The Cell Cycle
, Cell Cycle – duplication of cells = 2 identical daughter cells
o 4 stages:
G1(longest stage) – growth, transcription, etc
S – synthesis of new DNA
G2 – growth, transcription, etc.
M – mitosis + cytokinesis
Prophase, prometaphase, metaphase, anaphase, telophase,
cytokinesis
o Cycle checkpoints:
G1/S Checkpoint (most tightly regulated)
G2/M Checkpoint
Cell cycle regulated by Cdks (Cyclin-dependent kinases – phosphorylates), bind to
Cyclins
o Levels of Cyclin increase during mitosis (Cdk levels stay constant but need
Cyclin to activate)
Cyclin D = Cdk 4/6 – G1
Cyclin A + E = Cdk 2 – G1/S
Cyclin B = Cdk 1 – G2/M
Cyclin-Cdk Complex Regulation:
o Phosphorylation (dual – inhibitory + activating; dephos – remove inhibitory)
o Cdk Inhibitors (INK4 = Cyclin D + Cdk4/6, CIP/KIP = ANY complex)
o Degradation of Cyclins (ubiquitination = proteosome degradation)
The G1/S Transition (most tightly regulated)
o Growth factors/mitogens signal transcription of Cyclin D, forms complex with
Cdk 4/6
o Phosphorylates pRB (tumor suppressor/transcription factor) = released off of E2F
o Transcription of Cyclin A and E genes occurs, cycle proceeds to S phase
Positive Feedback Loop – Cyclin E/Cdk2 further phosphorylates pRB
Important to regulate b/c of Restriction (R) Point (committed to S phase,
no longer needs factors/mitogens)
o Regulation of Transition:
Positive: growth factors/mitogens, inhibit the Cdk inhibitors (INK4 – d/t
TGF-B)
Negative: withdrawal of factors/mitogens, cellular stress (ex. cell
adhesion)
The G1/S Checkpoint
o DNA damage signals for activation of p53 (tumor suppressor) by ATM kinase
o p53 activates transcription of CIP (broad Cdk inhibitor)
o CIP inhibits activity of Cyclin A/E + Cdk 2
The G2/M Checkpoint
o Cyclin B + Cdk 1 working here – increase activity of activating phosphatase
o DNA damage signals for activation of p53 by ATM kinase
ATM kinase also adds inhibitory phosphate onto activating phosphatase
o P53 activates transcription of CIP (broad)
o CIP inhibits activity of Cyclin B + Cdk 1
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller pingu70. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for CA$15.10. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
84866 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now
